AC group meningococcal (combined) Haemophilus influenzae type b (combined) vaccine(Beijing Zhifei Luzhu)

AC群脑膜炎球菌（结合）b型流感嗜血杆菌（结合）联合疫苗（北京智飞绿竹）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAC group meningococcal (combined) Haemophilus influenzae type b (combined) vaccine(Beijing Zhifei Luzhu)
Drug Alias Name喜贝康
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Conjugated vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisCellulitisSepsis +[8] 
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaMeningococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2014/04/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningitisCellulitisSepsis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07AG53
Related LinksN/A